Switch theme
Sign up to access all valuation multiples
Deepnoid Inc is a doctor-driven medical AI platform. It is an open platform that supports doctor-led medical imaging AI model research efficiently. It uses both the image processing module and neural network module provided by default for free, and can effectively use computing resources in the form of a cloud.
2008
n/a
LTM Revenue $9.2M
LTM EBITDA -$0.5M
$90.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Deepnoid has a last 12-month revenue of $9.2M and a last 12-month EBITDA of -$0.5M.
In the most recent fiscal year, Deepnoid achieved revenue of $7.4M and an EBITDA of -$5.5M.
Deepnoid expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Deepnoid valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.3M | $7.4M | XXX | XXX | XXX |
| Gross Profit | $1.1M | $0.6M | XXX | XXX | XXX |
| Gross Margin | 80% | 7% | XXX | XXX | XXX |
| EBITDA | -$4.1M | -$5.5M | XXX | XXX | XXX |
| EBITDA Margin | -309% | -74% | XXX | XXX | XXX |
| Net Profit | -$3.6M | -$4.6M | XXX | XXX | XXX |
| Net Margin | -276% | -62% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Deepnoid's stock price is KRW 6200 (or $4).
Deepnoid has current market cap of KRW 139B (or $94.7M), and EV of KRW 133B (or $90.9M).
See Deepnoid trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $90.9M | $94.7M | XXX | XXX | XXX | XXX | $-0.43 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Deepnoid has market cap of $94.7M and EV of $90.9M.
Deepnoid's trades at 9.9x LTM EV/Revenue multiple, and -172.4x LTM EBITDA.
Analysts estimate Deepnoid's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Deepnoid and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $90.9M | XXX | XXX | XXX |
| EV/Revenue | 12.3x | XXX | XXX | XXX |
| EV/EBITDA | -16.6x | XXX | XXX | XXX |
| P/E | -15.3x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -5.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDeepnoid's NTM/LTM revenue growth is 65%
Deepnoid's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Deepnoid's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Deepnoid's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Deepnoid and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 461% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -74% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 35% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -9% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 103% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Deepnoid acquired XXX companies to date.
Last acquisition by Deepnoid was XXXXXXXX, XXXXX XXXXX XXXXXX . Deepnoid acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Deepnoid founded? | Deepnoid was founded in 2008. |
| Where is Deepnoid headquartered? | Deepnoid is headquartered in South Korea. |
| Is Deepnoid publicy listed? | Yes, Deepnoid is a public company listed on KRX. |
| What is the stock symbol of Deepnoid? | Deepnoid trades under 315640 ticker. |
| When did Deepnoid go public? | Deepnoid went public in 2021. |
| Who are competitors of Deepnoid? | Similar companies to Deepnoid include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Deepnoid? | Deepnoid's current market cap is $94.7M |
| What is the current revenue of Deepnoid? | Deepnoid's last 12-month revenue is $9.2M. |
| What is the current EBITDA of Deepnoid? | Deepnoid's last 12-month EBITDA is -$0.5M. |
| What is the current EV/Revenue multiple of Deepnoid? | Current revenue multiple of Deepnoid is 9.9x. |
| What is the current EV/EBITDA multiple of Deepnoid? | Current EBITDA multiple of Deepnoid is -172.4x. |
| What is the current revenue growth of Deepnoid? | Deepnoid revenue growth between 2023 and 2024 was 461%. |
| Is Deepnoid profitable? | Yes, Deepnoid is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
